Skip to content

Prostate Cancer Biomarker Assay

A methylated DNA classifier to identify prostate cancer with over 90% sensitivity and specificity

Published: 15th February 2021
Prostate Cancer Biomarker Assay
Kateryna_Kon, stock.adobe.com
Patents
  • Filed PCT Patent WO 2020/069610 A1 "Prostate Cancer Biomarker Assays"
IP Status
  • Patent application submitted
Seeking
  • Licensing
  • Seeking investment
  • Development partner